Orphan Medicinal Products and patient Advocacy Group

Orphan drugs are medicinal products that are used to treat rare diseases. They are called “orphan drugs” because due to their limited in market, only few pharmaceutical companies pursue research into such products. These drugs would not be produce without government assistance.

List of orphan medicinal products in Europe with European orphan designation

 

  • Adcetris
  • Adempas
  • Hetlioz
  • ChenodeoxycHolicAcidLeadiant
  • Besponsa
  • Iclusig
  • Ketoconazlehra
  • Namuscla
  • Roxon

Related Conference of Orphan Medicinal Products and patient Advocacy Group

April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands
August 28-29, 2025

8th Pathology and Infectious Disease Conference

London, UK
September 22-23, 2025

11th International Conference on Infectious and Rare Diseases

Vancouver, Canada
December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic

Orphan Medicinal Products and patient Advocacy Group Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in